Online Database of Chemicals from Around the World 产品搜索 | 产品提交 | 产品推广

网站主页 >> 化工产品目录 >> 头孢比普酯>> 市场分析报告
 

头孢比普酯市场分析报告

Global Market Report of Ceftobiprole medocaril (CAS 376653-43-9)
December 2024

CAS 376653-43-9 Ceftobiprole medocaril Chemical Report & Database
CAS 376653-43-9 Ceftobiprole medocaril Chemical Report & Database This Ceftobiprole medocaril Chemical World ... . The Ceftobiprole medocaril World Consumption Report & Database definitions: Name: Ceftobiprole medocaril: Ceftobiprole medocaril Chemical ...

Global Antibacterial Drug Resistance Industry Research Report 2020, Forecast to 2025
... (Teflaro/ Zinforo) Fidaxomicin (Dificid / Dificlir) Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Dalbavancin (Dalvance ...

Global Antibacterial Drug Resistance Market Insight 2020, Forecast to 2025
... (Teflaro/ Zinforo) Fidaxomicin (Dificid / Dificlir) Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Dalbavancin (Dalvance ...

Complicated skin and soft tissue infections (cSSTI) - Pipeline Insight, 2021
... phase for treatment of cSSTI. Ceftobiprole medocaril: Basilea Pharmaceutica Ceftobiprole medocaril, the prodrug of the ... active moiety ceftobiprole, is a cephalosporin antibiotic ...

Global Antibacterial (Drug) Resistance Market Report 2020
... (Teflaro/ Zinforo) Fidaxomicin (Dificid / Dificlir) Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Dalbavancin (Dalvance ...

Global Antibacterial (Drug) Resistance Market Growth 2023-2029
... (Teflaro/ Zinforo) Fidaxomicin (Dificid / Dificlir) Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Dalbavancin (Dalvance ...

Global Antibacterial (Drug) Resistance Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
... (Teflaro/ Zinforo) Fidaxomicin (Dificid / Dificlir) Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Dalbavancin (Dalvance ...

Global Antibacterial (Drug) Resistance Market Status, Trends and COVID-19 Impact Report 2021
... (Teflaro/ Zinforo) Fidaxomicin (Dificid / Dificlir) Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Dalbavancin (Dalvance ...

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H1 2020
Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Methicillin-Susceptible Staphylococcus aureus Infections – Pipeline ...

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H2 2020
Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Methicillin-Susceptible Staphylococcus aureus Infections - Pipeline ...

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections (Infectious Disease) - Drugs in Development, 2021
Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Methicillin-Susceptible Staphylococcus aureus ...

Acute Bacterial Skin and Skin Structure Infections - Pipeline Insight, 2021
... Drugs Zevtera: Basilea Pharmaceutica Zevtera (Ceftobiprole medocaril), the prodrug of the active moiety ... ceftobiprole, is a cephalosporin antibiotic for intravenous administration ...

Endocarditis - Pipeline Insight, 2021
... ContraFect Basilea Key Products Exebacase Ceftobiprole medocaril

Anal Cancer - Pipeline Insight, 2021
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Anal Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Anal Cancer pipeline landscape. It covers the pipeline ...

Antibacterial (Drug) Resistance Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Electrical Utility Task Vehicles (UTV) in global, including the following market information: Global Electrical Utility Task Vehicles (UTV) Market Revenue, 2017-2022, 2023-2028, ($ millions) Global ...

Smart Texitile Market - Global Outlook and Forecast 2022-2028
... (Teflaro/ Zinforo) Fidaxomicin (Dificid / Dificlir) Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Dalbavancin (Dalvance ...

2023-2028 Global and Regional Antibacterial (Drug) Resistance Industry Status and Prospects Professional Market Research Report Standard Version
... (Teflaro/ Zinforo) Fidaxomicin (Dificid / Dificlir) Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Dalbavancin (Dalvance ...

Antibiotics Market Size, Share, Trends and Forecast by Action Mechanism, Drug Class, Spectrum of Activity, Route of Administration, End User, and Region, 2025-2033
... FDA’s approval in April 2023 of Zevtera (ceftobiprole medocaril sodium for injection), which is designed ...

Healthcare–associated Pneumonia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?
The 7 major healthcare–associated pneumonia markets reached a value of US$ 666.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 983.9 Million by 2034, exhibiting a growth rate (CAGR) of 3.61% during 2024-2034. The healthcare– ...




Copyright ©  chemBlink. 版权所有. 免责声明 | 网站简介 | 在线联系